{"record_key":"creegh-pharmaceuticals-inc","identifier":"creegh-pharmaceuticals-inc","external_key":"8D797A","title":"Creegh Pharmaceuticals, Inc.","summary":null,"url":"https://inventions.pitt.edu/startups/creegh-pharmaceuticals-inc","json_url":"https://inventions.pitt.edu/startups/creegh-pharmaceuticals-inc.json","object_key":"startups","description":"Creegh Pharmaceuticals is developing medicines inspired by nitroalkenes, naturally occurring molecules that help regulate inflammation, metabolism and cellular stress. Cofounded by Bruce A. Freeman and Francisco J. Schopfer, the Pittsburgh company draws on research connected to the University of Pittsburgh to pursue new approaches to inflammatory and degenerative disease. [1]: https://creegh.com/ [2]: https://www.coi.pitt.edu/sites/default/files/080723%20COI%20Website%20Posting%20for%20FCOIs.pdf\nIts development portfolio includes programs for obesity-associated asthma and Parkinson’s disease. The platform aims to influence several connected biological pathways, bringing the body’s own signaling mechanisms into the search for new treatment options. [1]: https://creegh.com/","attributes":[{"key":"website","label":"Website","values":["https://creegh.com/"]},{"key":"sector","label":"Sector","values":["Therapeutics"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Respiratory","Neuroscience","Immunology"]},{"key":"therapeutic_indications","label":"Therapeutic Indications","values":["Asthma"]},{"key":"funding_stage","label":"Funding Stage","values":["Seed"]},{"key":"founders","label":"Founders","values":["Bruce A. Freeman","Francisco J. Schopfer"]}],"related":[]}